Filing Details
- Accession Number:
- 0001209191-21-020418
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-15 15:24:53
- Reporting Period:
- 2021-03-11
- Accepted Time:
- 2021-03-15 15:24:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1328143 | Adamas Pharmaceuticals Inc | ADMS | Pharmaceutical Preparations (2834) | 421560076 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1832694 | Spyridon Papapetropoulos | C/O Adamas Pharmaceuticals, Inc. 1900 Powell Street, Suite 1000 Emeryville CA 94608 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-11 | 5,975 | $5.06 | 15,975 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The shares were purchased at prices ranging from $4.85 to $5.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
